- Home
- LOB vs IMTX Comparison
LOB vs IMTX Comparison
Compare LOB & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LOB | IMTX |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | LOB | IMTX |
|---|---|---|
| Price | $36.04 | $9.18 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $40.00 | $19.25 |
| AVG Volume (30 Days) | 333.3K | ★ 464.2K |
| Earning Date | 01-21-2026 | 11-17-2025 |
| Dividend Yield | ★ 0.33% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.49 | N/A |
| Revenue | ★ $434,209,000.00 | $99,445,031.00 |
| Revenue This Year | $44.86 | N/A |
| Revenue Next Year | $16.20 | $19.39 |
| P/E Ratio | $24.56 | ★ N/A |
| Revenue Growth | ★ 7.02 | N/A |
| 52 Week Low | $22.68 | $3.30 |
| 52 Week High | $41.56 | $12.41 |
Technical Indicators
Market Signals| Indicator | LOB | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 57.38 | 38.49 |
| Support Level | $33.93 | $9.13 |
| Resistance Level | $37.88 | $10.19 |
| Average True Range (ATR) | 1.05 | 0.49 |
| MACD | 0.03 | -0.13 |
| Stochastic Oscillator | 57.72 | 6.38 |
Price Performance
Historical ComparisonAbout LOB Live Oak Bancshares Inc.
Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.